Berry and oat shakes tested as Heart-Health boosters

NCT ID NCT03620266

Ongoing Disease control Sponsor: Ole Frobert, MD, PhD Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether daily shakes made from bilberries and oats can lower LDL cholesterol and improve exercise capacity in people who have had a heart attack or have type 2 diabetes. 900 participants will drink either a bilberry shake, an oat shake, a combination shake, or a placebo shake twice a day for three months. The goal is to see if these simple dietary additions can provide extra heart protection on top of standard medications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bilberry and oat shakes
What this could lead to: If it works, this could offer a simple, safe dietary strategy to help manage cholesterol and inflammation in people with heart disease or diabetes.
What could go wrong: This is a mid-sized study, not a large final-stage trial. The effects may be small or not clinically meaningful, and the shakes are taken alongside standard medications, not replacing them.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOCARDIAL INFARCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myocardial infarction type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOCARDIAL INFARCTION

Contacts and locations

Locations

Cardiology Clinic, Västmanlands sjukhus

Västerås, 721 89, Sweden
Department of Cardiology, Skånes universitetssjukhus

Lund, 221 00, Sweden
Department of Cardiology, Örebro University Hospital

Örebro, 701 85, Sweden
Falu lasarett

Falun, Sweden
Karlstad general hospital

Karlstad, Sweden
Odense University Hospital

Odense, Denmark
Sahlgrenska Universitetssjukhuset

Gothenburg, Sweden
Steno Diabetes center

Aarhus, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.